[1] |
LU Xiya, LI Yuxing, LI Wenzhi, PENG Yuanyuan, HU Yi, WAN Li, CHEN Bilian.
Analysis of prescribing of antiplatelet drug in patients with coronary heart disease in department of geriatrics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1285-1291.
|
[2] |
XIA Chunyong, ZHANG Zuowen, HE Xiaoyan, LIU Jie, LI Xiaoya, CHANG Qiuhong, QIN Lijuan, CAO Zhenming, DING Ling.
Correlation between CYP2C19 gene polymorphism and individualized medication in patients with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 318-323.
|
[3] |
YUAN Zhen, CHEN Bilian.
Review of bleeding events in clinical studies of clopidogrel
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 341-349.
|
[4] |
XU Honglei, XU Bingxin, ZU Qing, ZHAO Yan, GAO Pengfei, YU Yang.
Effects of CYP2C19 gene polymorphism on the clinical prognosis of clopidogrel in elderly patients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1014-1020.
|
[5] |
PENG Jing, LIU Jun, XU Huifang, LI Yueran, JIANG Jia, WANG Sheng, ZHOU Dexi, ZHU Yanhong, YANG Kui, LUAN Jiajie.
Correlation study between cytochrome P4502C19 gene polymorphism or metabolic type and ADP induced-platelet aggregation inhibition and clopidogrel resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 746-751.
|
[6] |
YANG Rui, LIU Hui, CHEN Zeheng, QI Tingting,ZHANG Zanling, QU Qiang.
Clinical pharmacists use CYP2C19 genotyping test to guide individual medication therapy of Clopidogrel and to evaluate the efficacy of treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 938-943.
|
[7] |
CHEN Hongzhu, LIU Jianming, ZHOU Fang, JIA Yuanwei, WANG Guangji, ZHANG Jingwei.
Effect and mechanism of endogenous metabolism on drug metabolism and disposition
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 580-588.
|
[8] |
WANG Weiyu, YU Hao.
Effects of gray drugs in patients with coronary heart disease: A network Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 301-307.
|
[9] |
DONG Man-man, YANG Hong-wei.
Endogenous cannabinoid system and Alzheimer Disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 943-947.
|
[10] |
LIU Bei, LIANG Sheng-wang.
Progress of metabonomic study on cerebral ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 828-834.
|
[11] |
ZHANG Xia, KE Yong-sheng.
Clinical research of new type P2Y12 Receptor inhibitor ticagrelor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 459-464.
|
[12] |
YANG Yong-ge, ZHANG Mei, JIANG Nan, SONG Li-xue, XU Xue-ting, DI Xiao-hui, XU Lin, XU Juan,ZHAO Gang-tao.
Bioequivalence of clopidogrel hydrogen sulfate tablets in healthy Chinese volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 38-43.
|
[13] |
WANG Xin-gang, HUANG Yu-rong, LI Quan-sheng, SI Duan-yun.
Bioequivalence study of endogenous drugs by iodine preparations
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(2): 181-185.
|
[14] |
YUN Wen-bo1, JIANG Peng-li1, WU Jing1, SUN He1,2.
Bleeding risk is higher when warfarin used alone compared to the associated use of aspirin with clopidogrel
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1251-1259.
|
[15] |
WANG Wu-san, JI Hui, XIE Hai-tang, DAI Min, JIA Yuan-wei, LIANG Da-hu, YE Lei, RONG Zu-yuan.
A sensitive and specific UPLC-MS/MS analysis and preliminary pharmacokinetic characterization of S-oxiracetam in Beagle dogs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 988-995.
|